How is avelumab given and how long is each infusion?

Avelumab is prepared by a pharmacy and administered as an intravenous infusion in a clinic or hospital. Infusions are typically given over about 60 minutes. The initial doses are often scheduled every 2 weeks, following the approved indication. Nurses monitor for infusion reactions during and after administration. Only a trained healthcare professional should prepare and give the infusion. Your individual schedule follows the official label and your prescriber’s plan.

What are common side effects to watch for?

Common effects include fatigue, fever or chills around infusion days, nausea, decreased appetite, diarrhea, rash, cough, and muscle or joint pain. Immune‑related reactions can affect the lungs, liver, kidneys, endocrine glands, or skin. Contact your healthcare professional promptly for chest pain, shortness of breath, severe diarrhea, severe rash, yellowing of the skin or eyes, or confusion. Clinics monitor for infusion reactions and can treat them as needed.

Who should avoid this immunotherapy?

People with active, serious autoimmune disease or those who require chronic systemic immunosuppression may not be candidates. Caution is advised in patients with organ transplants or uncontrolled infections. Risks during pregnancy and breastfeeding should be discussed with a prescriber. Live vaccines are generally avoided during treatment. Your clinician will review your full medical history and medicines before deciding if this therapy is appropriate.

Can I receive vaccines while on treatment?

Live vaccines are typically avoided during therapy because they may pose safety risks when immune function is altered. Inactivated or non‑live vaccines may be considered, but timing should be coordinated with your prescriber. Always tell your healthcare professional about upcoming immunizations so they can advise on which vaccines are appropriate and when to receive them relative to infusion dates.

How is dosing determined for my condition?

Dosing follows the official labeling for each indication. Adults commonly receive 800 mg by IV infusion every 2 weeks. In renal cell carcinoma, it may be combined with axitinib per the combination’s label. Your oncology team determines duration and any adjustments based on response and tolerability. Never change your schedule without guidance from your prescriber. If you miss a visit, contact your clinic to reschedule.

How is the medicine stored and handled?

Vials are stored under refrigeration and protected from light per the label. Pharmacies and clinics maintain appropriate conditions and prepare doses for infusion. Patients typically do not manage storage. If you travel for care, coordinate with your clinic about appointment timing and ensure you bring identification and insurance details as needed. Handling and disposal of supplies are performed by trained staff at the infusion site.

Will insurance cover this therapy and what are options if not?

Coverage varies by plan, treatment setting, and diagnosis. Hospital outpatient or specialty pharmacy channels may process claims differently from community clinics. If coverage is limited, your prescriber and pharmacy can review alternatives, manufacturer support programs, or timing of fills. We can discuss Canadian pricing and self‑pay options to help you compare access pathways while you work with your healthcare professional.

Promotion

Bavencio

Bavencio® Injection for Merkel Cell Carcinoma

Bladder Cancer (Urothelial Carcinoma), Kidney Cancer (Renal Cell Carcinoma), Merkel Cell Carcinoma

Please note: a valid prescription is required for all prescription medication.

Stock up and Save - Get 20% off when you buy 3 or more of any one product. Use code SAVE20 at checkout.

Coupon code cannot be combined with other offers. Sale applies to all products originating from Canada. Maximum allowable quantity equal to a 90 day supply per single order.

Price:

$1,650.99

Secure Encrypted Payments

Bavencio is a prescription immunotherapy for certain cancers in adults. It blocks PD‑L1 to help your immune system recognize and attack cancer cells. This page explains what it treats, how it is given, safety basics, and how to access it through our pharmacy.

What Bavencio Is and How It Works

Bavencio® (avelumab) is a monoclonal antibody that targets PD‑L1. By blocking this checkpoint, it can restore T‑cell activity against tumor cells. YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing. Ships from Canada to US options and questions about Avelumab cost without insurance are covered below to help you plan access with your care team.

This medicine is given as an intravenous infusion by trained professionals. It may be used alone or with other anticancer agents, depending on the indication. Always follow the official prescribing information and your clinician’s instructions.

Who It’s For

This treatment is indicated for adults with metastatic Merkel cell carcinoma. It is also used as first‑line therapy in combination with axitinib for advanced renal cell carcinoma, and as maintenance therapy for locally advanced or metastatic urothelial carcinoma that has not progressed after platinum‑containing chemotherapy. People with active, serious autoimmune disease or those requiring chronic systemic immunosuppression may not be suitable. Ask your prescriber about eligibility and how Bavencio price considerations may fit your care plan.

Dosage and Usage

Standard adult dosing follows approved labeling:

Merkel cell carcinoma: 800 mg administered by IV infusion over about 60 minutes every 2 weeks.
Urothelial carcinoma maintenance: 800 mg by IV infusion every 2 weeks after initial platinum‑based chemotherapy without progression.
Advanced renal cell carcinoma: 800 mg every 2 weeks in combination with axitinib, following each product’s label.

Infusions are prepared and given in a healthcare setting. Pre‑medication and monitoring may be used per institutional protocols. Dose delays or discontinuation may be considered for immune‑related adverse reactions per the label. When uncertain, defer to the official prescribing information.

Strengths and Forms

Avelumab is supplied as a single‑dose vial for dilution prior to infusion. Commonly published presentation: 200 mg/10 mL vial (20 mg/mL). Availability may vary by jurisdiction and supplier. The vial is diluted into an infusion bag and given intravenously under professional supervision.

Questions about Bavencio 20 mg/mL injection price often relate to vial strength and number of vials used per visit. Your clinic determines preparation based on your prescribed dose.

Missed Dose and Timing

If an infusion appointment is missed, contact your clinic to reschedule. Do not attempt to self‑administer this medicine. Timing adjustments are made by your healthcare professional to keep your treatment plan aligned with the label and your clinical status.

Storage and Travel Basics

Vials are stored by pharmacies and clinics under refrigeration and protected from light per labeling. Do not freeze. Because this is clinic‑administered, patients usually do not handle vials directly. If you are coordinating travel for treatment, keep appointment documentation accessible and confirm infusion arrangements in advance. For home storage questions or transfers between sites, your care team will advise according to the product label.

Pen Handling and Sharps Disposal

This therapy is not supplied as a pen or self‑injector. Infusion supplies and sharps disposal are handled by the administering facility according to local regulations.

Benefits

This checkpoint inhibitor can help the immune system recognize certain cancers. It may be used alone or with targeted agents in defined settings. Clinic administration avoids self‑injection steps. Scheduling every 2 weeks provides a predictable cadence for monitoring. If you are assessing access, our team can explain how Avelumab price information intersects with treatment planning.

Side Effects and Safety

Common effects can include:

Infusion‑related reactions such as chills, fever, or flushing
Fatigue and weakness
Nausea, decreased appetite, or diarrhea
Skin rash or itching
Cough or shortness of breath
Muscle or joint pain

Serious immune‑related reactions may affect the lungs, liver, kidneys, endocrine glands, skin, or other organs. These can be severe or fatal if not recognized. Call your healthcare professional promptly for new or worsening symptoms such as chest pain, severe cough, yellowing of the skin or eyes, severe abdominal pain, severe diarrhea, severe rash, or confusion. Infusion reactions can occur during or after administration; clinics monitor and manage these events.

Drug Interactions and Cautions

Before starting, tell your prescriber about all medicines, supplements, and vaccines. Concomitant systemic corticosteroids or other immunosuppressants may blunt immune response and are used cautiously outside of managing adverse reactions. Live vaccines are generally avoided during therapy. Patients with organ transplants, active autoimmune disease, or chronic infections require careful assessment. Pregnancy and lactation risks are addressed in labeling; discuss contraception and breastfeeding guidance with your clinician.

What to Expect Over Time

Your care team monitors you with regular visits and lab checks. Some people notice early fatigue or infusion‑related symptoms on treatment days. Immune‑related effects can appear weeks or months after starting, so ongoing communication is important. Keep a simple symptom diary and bring it to appointments. Consistent scheduling supports assessment and timely management of side effects. For background reading, see our article on Skin Cancer and seasonal awareness around Lung Cancer.

Compare With Alternatives

Other approved options may be considered based on cancer type and prior therapy. For urothelial carcinoma and other settings, PD‑L1 or PD‑1 inhibitors such as Imfinzi may be discussed with your oncology team. For advanced renal cell carcinoma, targeted agents like Inlyta are sometimes used, including in combinations per label. Access considerations and Avelumab price from Canada topics can be reviewed alongside these alternatives.

Pricing and Access

We offer Canadian pharmacy fulfillment with Merkel Cell and related oncology needs. See product details to review current options and how US delivery from Canada works for oncology prescriptions. If you are comparing options, we can clarify Bavencio price from Canada and clinic supply logistics. For current offers, visit our Promotions page. Encrypted checkout is supported.

Insurance coverage varies by plan and setting. Hospital outpatient billing and specialty pharmacy channels may differ from community oncology clinics. Our team can coordinate with your prescriber on documentation required to dispense through our pharmacy.

Availability and Substitutions

Supply can vary by manufacturer allocation and regulatory market. If this item is temporarily unavailable, your prescriber may recommend an appropriate alternative that aligns with your diagnosis and treatment history. A valid prescription is required; prescription required and verified for all oncology medicines before dispensing.

Patient Suitability and Cost-Saving Tips

Candidates are adults whose cancer and overall health fit the approved uses. Those with severe uncontrolled autoimmune disease or active infections may not be suitable. If you and your prescriber decide to use this therapy, consider these access tips:

Multi‑month planning: ask your clinic about scheduling several cycles ahead.
Refill reminders: set alerts so your clinician and pharmacy can coordinate supply.
Clinic coordination: confirm infusion site policies for receipt and preparation.
Coverage review: have your provider submit required forms to support access.
Category research: explore our Urothelial Carcinoma, Kidney Cancer, and Cancer pages for related options.

Questions to Ask Your Clinician

Is this immunotherapy appropriate for my cancer stage and prior treatments?
What symptoms should prompt immediate contact between visits?
How will infusions be scheduled and monitored at my clinic?
What labs or imaging will you use to assess response and safety?
How do other medicines I take affect safety or effectiveness?
If I need to pause therapy for side effects, what is the plan to restart?

Authoritative Sources

Manufacturer Information

FDA Prescribing Information

Health Canada Drug Product Database

Close and Next Steps

Ready to proceed? Review details, share your prescription, and Order Avelumab online with YouDrugstore. We provide prompt, express, cold-chain shipping with US shipping from Canada. This content is for general information and does not replace your clinician’s advice or the official label.

Express Shipping - from $25.00

Shipping with this method takes 3-5 days

Prices:

Dry-Packed Products $25.00
Cold-Packed Products $35.00

Shipping Countries:

United States (all contiguous states**)
Worldwide (excludes some countries***)

Standard Shipping - $15.00

Shipping with this method takes 5-10 days

Prices:

Dry-Packed Products $15.00
Not available for Cold-Packed products

Shipping Countries:

United States (all contiguous states**)
Worldwide (excludes some countries***)

View All FAQs

How is avelumab given and how long is each infusion?
Avelumab is prepared by a pharmacy and administered as an intravenous infusion in a clinic or hospital. Infusions are typically given over about 60 minutes. The initial doses are often scheduled every 2 weeks, following the approved indication. Nurses monitor for infusion reactions during and after administration. Only a trained healthcare professional should prepare and give the infusion. Your individual schedule follows the official label and your prescriber’s plan.
What are common side effects to watch for?
Common effects include fatigue, fever or chills around infusion days, nausea, decreased appetite, diarrhea, rash, cough, and muscle or joint pain. Immune‑related reactions can affect the lungs, liver, kidneys, endocrine glands, or skin. Contact your healthcare professional promptly for chest pain, shortness of breath, severe diarrhea, severe rash, yellowing of the skin or eyes, or confusion. Clinics monitor for infusion reactions and can treat them as needed.
Who should avoid this immunotherapy?
People with active, serious autoimmune disease or those who require chronic systemic immunosuppression may not be candidates. Caution is advised in patients with organ transplants or uncontrolled infections. Risks during pregnancy and breastfeeding should be discussed with a prescriber. Live vaccines are generally avoided during treatment. Your clinician will review your full medical history and medicines before deciding if this therapy is appropriate.
Can I receive vaccines while on treatment?
Live vaccines are typically avoided during therapy because they may pose safety risks when immune function is altered. Inactivated or non‑live vaccines may be considered, but timing should be coordinated with your prescriber. Always tell your healthcare professional about upcoming immunizations so they can advise on which vaccines are appropriate and when to receive them relative to infusion dates.
How is dosing determined for my condition?
Dosing follows the official labeling for each indication. Adults commonly receive 800 mg by IV infusion every 2 weeks. In renal cell carcinoma, it may be combined with axitinib per the combination’s label. Your oncology team determines duration and any adjustments based on response and tolerability. Never change your schedule without guidance from your prescriber. If you miss a visit, contact your clinic to reschedule.
How is the medicine stored and handled?
Vials are stored under refrigeration and protected from light per the label. Pharmacies and clinics maintain appropriate conditions and prepare doses for infusion. Patients typically do not manage storage. If you travel for care, coordinate with your clinic about appointment timing and ensure you bring identification and insurance details as needed. Handling and disposal of supplies are performed by trained staff at the infusion site.
Will insurance cover this therapy and what are options if not?
Coverage varies by plan, treatment setting, and diagnosis. Hospital outpatient or specialty pharmacy channels may process claims differently from community clinics. If coverage is limited, your prescriber and pharmacy can review alternatives, manufacturer support programs, or timing of fills. We can discuss Canadian pricing and self‑pay options to help you compare access pathways while you work with your healthcare professional.